Silver Book Fact

A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of patients with a range of conditions including neuropathic and musculoskeletal pain.

Kerns R, Kassirer M, Otis J. Pain in Multiple Sclerosis: A biopsychosocial perspective. J Rehabil Res Dev. 2002; 39(2): 225-32. http://www.rehab.research.va.gov/jour/02/39/2/pdf/kerns.pdf

Reference

Title
Pain in Multiple Sclerosis: A biopsychosocial perspective
Publication
J Rehabil Res Dev
Publication Date
2002
Authors
Kerns R, Kassirer M, Otis J
Volume & Issue
Volume 39, Issue 2
Pages
225-32
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • Statin use in mouse models show pain-alleviating effects for neuropathic pain.